Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Product: Diprivan 2% w/v. Active Ingredient(s): Propofol 20 mg/mL. Dosage Form: Emulsion for injection. NZ Sponsor: AstraZeneca Limited. Manufacturer(s): Zeneca SpA, Divisione Farmaceutici, Caponago, Milan, Italy. Product: MonoFix-VF. Active Ingredient(s): Factor IX 50 IU/mL. Dosage Form: Powder for injection. NZ Sponsor: CSL (New Zealand) Limited. Manufacturer(s):CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia. Product: Regranex. Active Ingredient(s): Becaplermin 0.1 mg/g. Dosage Form: Topical gel. NZ Sponsor: Janssen-Cilag Pty Limited. Manufacturer(s): OMJ Pharmaceuticals Inc., Industrial Park North, San German, Puerto Rico. Dated this 9th day of August 1999. G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).